LEADER 01865nam  2200385   450 
001 9910683371303321
005 20230627133343.0
010   $a3-0365-7074-8
035   $a(CKB)5700000000354518
035   $a(NjHacI)995700000000354518
035   $a(EXLCZ)995700000000354518
100   $a20230627d2023      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNeurodegenerative Diseases $eFrom Molecular Basis to Therapy /$fedited by Marcello Ciaccio, Luisa Agnello
210  1$aBasel, Switzerland :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2023.
215   $a1 online resource  (262 pages)
311   $a3-0365-7075-6 
330   $aNeurodegenerative diseases (NDs) are a heterogeneous group of complex diseases characterized by neuronal loss and progressive degeneration of different areas of the nervous system. NDs represent a significant health problem worldwide, with an increasing incidence rate. Although the exact pathogenesis of NDs remains unclear, a complex interaction among genetic, epigenetic, and environmental factors has been proposed. To date, no effective therapeutics have been developed to slow, halt, or prevent any NDs. Thus, information on the molecular mechanisms underlying the pathogenesis of NDs is strongly sought after. This Special Issue collected papers discussing advances in the field of NDs.
606   $aNerve Degeneration
606   $aNeurodegenerative Diseases
615  0$aNerve Degeneration.
615  0$aNeurodegenerative Diseases.
676   $a616.8/047
702   $aCiaccio$b Marcello
702   $aAgnello$b Luisa
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910683371303321
996   $aNeurodegenerative Diseases$91522227
997   $aUNINA